These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29290211)

  • 61. CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti- Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells.
    Novitasari D; Jenie RI; Utomo RY; Kato JY; Meiyanto E
    Asian Pac J Cancer Prev; 2021 Jun; 22(6):1827-1836. PubMed ID: 34181339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diaphanous-related formin-3 overexpression inhibits the migration and invasion of triple-negative breast cancer by inhibiting RhoA-GTP expression.
    Jiang J
    Biomed Pharmacother; 2017 Oct; 94():439-445. PubMed ID: 28779705
    [TBL] [Abstract][Full Text] [Related]  

  • 63. hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.
    Park S; Sung Y; Jeong J; Choi M; Lee J; Kwon W; Jang S; Park SJ; Kim HS; Lee MH; Kim DJ; Liu K; Kim SH; Dong Z; Ryoo ZY; Kim MO
    Oncotarget; 2017 Jun; 8(23):37115-37127. PubMed ID: 28415749
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment.
    Chovancova B; Liskova V; Miklikova S; Hudecova S; Babula P; Penesova A; Sevcikova A; Durinikova E; Novakova M; Matuskova M; Krizanova O
    Biochem Pharmacol; 2020 Jan; 171():113695. PubMed ID: 31706846
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fatty acid binding protein 7 mediates linoleic acid-induced cell death in triple negative breast cancer cells by modulating 13-HODE.
    Kwong SC; Abd Jamil AH; Rhodes A; Taib NA; Chung I
    Biochimie; 2020 Dec; 179():23-31. PubMed ID: 32931863
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Triple-negative Breast Cancer Cell Line MDA-MB 231 Is Specifically Inhibited by the Ionophore Salinomycin.
    Hero T; Bühler H; Kouam PN; Priesch-Grzeszowiak B; Lateit T; Adamietz IA
    Anticancer Res; 2019 Jun; 39(6):2821-2827. PubMed ID: 31177119
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ICAM1 expression is induced by proinflammatory cytokines and associated with TLS formation in aggressive breast cancer subtypes.
    Figenschau SL; Knutsen E; Urbarova I; Fenton C; Elston B; Perander M; Mortensen ES; Fenton KA
    Sci Rep; 2018 Aug; 8(1):11720. PubMed ID: 30082828
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular heterogeneity in breast carcinoma cells with increased invasive capacities.
    Negro G; Aschenbrenner B; Brezar SK; Cemazar M; Coer A; Gasljevic G; Savic D; Sorokin M; Buzdin A; Callari M; Kvitsaridze I; Jewett A; Vasileva-Slaveva M; Ganswindt U; Skvortsova I; Skvortsov S
    Radiol Oncol; 2020 Feb; 54(1):103-118. PubMed ID: 32061169
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential Glucocorticoid-Dependent Regulation and Function of the ERRFI1 Gene in Triple-Negative Breast Cancer.
    Mojica CAR; Ybañez WS; Olarte KCV; Poblete ABC; Bagamasbad PD
    Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32432675
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pseudopterosin Inhibits Proliferation and 3D Invasion in Triple-Negative Breast Cancer by Agonizing Glucocorticoid Receptor Alpha.
    Sperlich J; Teusch N
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30103404
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks.
    Alshareeda AT; Rakha E; Alghwainem A; Alrfaei B; Alsowayan B; Albugami A; Alsubayyil AM; Abomraee M; Mohd Zin NK
    PLoS One; 2018; 13(11):e0207593. PubMed ID: 30458011
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biomarkers of DNA Repair and Related Pathways: Significance of Treatment in Triple-Negative Breast Cancer.
    Guo W; Lin L; He X; He F; Wang C; Chen N; Wang Y
    Crit Rev Oncog; 2017; 22(5-6):427-437. PubMed ID: 29604922
    [TBL] [Abstract][Full Text] [Related]  

  • 73. LRP8 is overexpressed in estrogen-negative breast cancers and a potential target for these tumors.
    Maire V; Mahmood F; Rigaill G; Ye M; Brisson A; Némati F; Gentien D; Tucker GC; Roman-Roman S; Dubois T
    Cancer Med; 2019 Jan; 8(1):325-336. PubMed ID: 30575334
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes.
    Amaral MEA; Nery LR; Leite CE; de Azevedo Junior WF; Campos MM
    Invest New Drugs; 2018 Oct; 36(5):782-796. PubMed ID: 29392539
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel.
    Simu S; Marcovici I; Dobrescu A; Malita D; Dehelean CA; Coricovac D; Olaru F; Draghici GA; Navolan D
    Molecules; 2021 May; 26(9):. PubMed ID: 34066763
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses.
    El Khalki L; Maire V; Dubois T; Zyad A
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31991634
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.
    Gari HH; Gearheart CM; Fosmire S; DeGala GD; Fan Z; Torkko KC; Edgerton SM; Lucia MS; Ray R; Thor AD; Porter CC; Lambert JR
    Oncotarget; 2016 Mar; 7(13):15757-71. PubMed ID: 26909599
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets.
    Gupta I; Rizeq B; Vranic S; Moustafa AA; Al Farsi H
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942528
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Triorganotin Isothiocyanates Affect Migration and Immune Check-point Receptors in Human Triple-negative Breast Carcinoma MDA-MB-231 Cells.
    Hunakova L; Horvathova E; Gronesova P; Bobal P; Otevrel J; Brtko J
    Anticancer Res; 2019 Sep; 39(9):4845-4851. PubMed ID: 31519587
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunological therapy: A novel thriving area for triple-negative breast cancer treatment.
    Wang X; Qi Y; Kong X; Zhai J; Li Y; Song Y; Wang J; Feng X; Fang Y
    Cancer Lett; 2019 Feb; 442():409-428. PubMed ID: 30419345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.